Mount Sinai’s new Institute for Liver Research has awarded its first two $30K pilot grants to support innovative projects in basic, translational, and clinical research—advancing collaboration and discovery in liver health. @DOMSinaiNYC Learn more: https://t.co/KTCqdraLme

Oh hello, Dr. Majid - we missed you so had to come find you over in the other corner of the UES! @WeillCornell @DOMSinaiNYC

"Using Predictive Models & #AI for #AKI Research" #Nephrology fellow Dr. Madhumitha Rajagopal et al. https://t.co/HvNektzJD6 @DOMSinaiNYC

"Underappreciated Health Benefits of Edible #Mushrooms in the Dietary Management of #CKD" - Dr. Jaime Uribarri et al. 🍄🍄‍🫘 https://t.co/xFfiWeYJ8s @DOMSinaiNYC @JReN_Social @nkf @lowage #Nephrology

A wonderful @DOMSinaiNYC Grand Rounds today from endocrinologist Dr. Reshmi Srinath on “Clinical Pearls in the Medical Management of Weight/Obesity.” By 2030, nearly half of Americans will be obese - with this increasing prevalence, however, we have an increasing armamentarium💊

Cost and access barriers are driving patients toward compounded GLP-1s—but what are the risks? Drs. @Neil_Iyengar (@WinshipAtEmory) and Emily Gallagher (@DOMSinaiNYC) unpack the clinical and safety considerations: https://t.co/gSoiX7Opcu @MWeintraubMD @scottisaacsmd @BevTchangMD

Thank you to everyone who joined the 11th Annual Advances in Peritoneal Dialysis Symposium! We’re grateful to the patients who shared their stories and to all who contributed to the inspiring discussions advancing home dialysis care. #PeritonealDialysis

Chiefs Happy Hour with our beloved System Vice Chair for Education! @AMalone2012 @DOMSinaiNYC

Honored to have @reshmagar, Director of @Yale_CRRIT, as the awardee of our Skolnick Lectureship in Humanism in Medicine at our @DOMSinaiNYC Grand Rounds on “Guarding the Public’s Health: Reinforcing FDA’s Role in Drug and Device Oversight.” Thank you, Dr. Ramachandran!

Join us for the 20th Annual Mid-Atlantic Hospital Medicine Symposium, a one-day event for hospitalists & internal medicine professionals. October 24, 2025 @DOMSinaiNYC Register: https://t.co/ajxt40lJUP

John Mascarenhas, MD, discusses the potential role of imetelstat in transforming the treatment landscape for patients with myelofibrosis, highlighting its promise in improving outcomes for those with limited therapeutic options. @OncLive https://t.co/jm2TMJ7eUg

New hope for multiple myeloma: immunotherapies like CAR T and bispecific antibodies are turning a once-fatal disease into a treatable one. “CAR T-cell therapy … no other drug … has shown that kind of curative potential.” — Dr. Sundar Jagannath https://t.co/WpKu4fNAcW

We’re proud to celebrate the recipients of the Cullman Family Award for Excellence in Provider Communication at Mount Sinai. Congratulations to all honorees for ranking in the top 5% nationwide for outstanding, compassionate communication! #MountSinaiProud

We are pleased to announce Michael Via, MD as Medical Director of Endocrinology, Diabetes & Bone Disease at Mount Sinai Downtown, effective Oct. 1, 2025. A master clinician and mentor, his expertise in thyroid & metabolic care draws patients worldwide. @MountSinaiEndo

We are proud to share that Peter Gliatto, MD, has been awarded the 2025 House Call Physician of the Year Award by AAHCM, honoring his excellence, innovation, and dedication in the field of home care medicine. @AAHCMedicine @IcahnMountSinai

Researchers at Mount Sinai have shown that adding a simple “lookup step” can make artificial intelligence significantly better at assigning medical diagnosis codes—sometimes even outperforming physicians. Published in NEJM AI, the study demonstrates how this retrieval-enhanced

Aniwaa Owusu Obeng, PharmD, shares how Mount Sinai is advancing precision care through pharmacogenomics, integrating clinical care, research, and education into pharmacy operations. @BeckersHR https://t.co/v6AcaKEZ2a

Researchers at @TischCancer, @IcahnMountSinai achieved the first successful treatment of a rare T-cell lymphoma after CAR T-cell therapy, using an FDA-approved antibody to induce remission. Published in @NEJM. Learn more: https://t.co/bD88D4rcMB

Resilience and coping are critical in IBD care. @RyanUngaro, MD, & Laurie Keefer, PhD discuss their research on brain-gut behavior therapy (BGBT) alongside medical treatment to improve outcomes for patients with #Crohndisease. https://t.co/G8546tnGXA

A new study led by Dr. Rohit Nathani highlights the cost impact of AASLD/AGA diabetes screening guidance, revealing disparities in access and the value of age-adjusted FIB-4 cutoffs. Learn more: https://t.co/eEbzCnngWQ @DOMSinaiNYC